LHC Group (LHCG) Upgraded to Strong-Buy at BidaskClub

BidaskClub upgraded shares of LHC Group (NASDAQ:LHCG) from a buy rating to a strong-buy rating in a report released on Wednesday.

Other research analysts have also recently issued reports about the stock. William Blair reiterated a buy rating on shares of LHC Group in a research report on Sunday, May 6th. ValuEngine raised LHC Group from a hold rating to a buy rating in a research note on Saturday, June 2nd. Craig Hallum increased their price objective on LHC Group from $70.00 to $80.00 and gave the company a buy rating in a research note on Wednesday, April 4th. Jefferies Financial Group reissued a buy rating and set a $84.00 price objective on shares of LHC Group in a research note on Wednesday, April 4th. Finally, Stephens set a $74.00 price objective on LHC Group and gave the company a buy rating in a research note on Friday, March 2nd. One research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. The stock has a consensus rating of Buy and a consensus price target of $77.33.

LHC Group opened at $82.28 on Wednesday, MarketBeat reports. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.24. The company has a market capitalization of $1.46 billion, a P/E ratio of 34.00, a P/E/G ratio of 1.27 and a beta of 0.68. LHC Group has a 1-year low of $56.76 and a 1-year high of $82.55.



LHC Group (NASDAQ:LHCG) last issued its quarterly earnings results on Wednesday, May 2nd. The health services provider reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.60 by $0.03. LHC Group had a net margin of 4.07% and a return on equity of 9.29%. The business had revenue of $291.10 million for the quarter, compared to analysts’ expectations of $295.21 million. During the same period last year, the business earned $0.53 earnings per share. The business’s quarterly revenue was up 19.2% on a year-over-year basis. sell-side analysts predict that LHC Group will post 3.5 earnings per share for the current year.

In other news, insider Joshua L. Proffitt sold 10,556 shares of the stock in a transaction that occurred on Thursday, May 17th. The stock was sold at an average price of $75.20, for a total transaction of $793,811.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Donald Dwayne Stelly sold 3,307 shares of the stock in a transaction that occurred on Monday, June 11th. The shares were sold at an average price of $79.76, for a total value of $263,766.32. Following the sale, the chief operating officer now directly owns 109,145 shares of the company’s stock, valued at approximately $8,705,405.20. The disclosure for this sale can be found here. In the last three months, insiders have sold 16,863 shares of company stock valued at $1,274,628. Insiders own 6.80% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. SG Americas Securities LLC purchased a new stake in LHC Group in the first quarter worth $105,000. Envestnet Asset Management Inc. purchased a new stake in LHC Group in the first quarter worth $134,000. LS Investment Advisors LLC lifted its stake in LHC Group by 249.5% in the fourth quarter. LS Investment Advisors LLC now owns 2,478 shares of the health services provider’s stock worth $152,000 after acquiring an additional 1,769 shares during the period. Cubist Systematic Strategies LLC lifted its stake in LHC Group by 36.9% in the first quarter. Cubist Systematic Strategies LLC now owns 2,636 shares of the health services provider’s stock worth $162,000 after acquiring an additional 711 shares during the period. Finally, Jefferies Group LLC purchased a new stake in LHC Group in the fourth quarter worth $200,000. 93.93% of the stock is owned by institutional investors.

About LHC Group

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply